The U.S. FDA says that studies show little benefit of hydroxychloroquine for COVID-19 patients, and relatively high risks of using the drug.
against the disease, and that it carries a risk of significant side effects, including heart problems.to the Biomedical Advanced Research and Development Authority on Monday. “Today’s request to revoke is based on new information, including clinical trial data results, that have led BARDA to conclude that this drug may not be effective to treat COVID-19,” she wrote, adding that it is “no longer reasonable” to believe that the drug combination’s benefits outweigh the potential side effects.
Hydroxychloroquine is a slightly different version of chloroquine, a drug discovered to fight malaria decades ago. Scientists developed hydroxychloroquine as a replacement for malaria treatment, with fewer side effects; today, in the U.S. it’s mainly prescribed to treat the inflammation related to autoimmune disorders like rheumatoid arthritis and lupus.
As the U.S. pandemic surged in March, President Donald Trump championed hydroxychloroquine as a potential COVID-19 treatment, calling it a possible “
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA terminates emergency use authorization of hydroxychloroquine for Covid-19The FDA pulls its emergency use authorization of hydroxychloroquine for Covid-19 treatment, citing the latest scientific evidence
Read more »
FDA Pulls Emergency Covid-19-Use Approval for Two Malaria Drugs Touted by TrumpBreaking: The FDA has revoked its emergency-use authorization for two malaria drugs, chloroquine and hydroxychloroquine, for the treatment of Covid-19. Both were widely touted by President Trump and others as useful in helping coronavirus patients.
Read more »
FDA pulls emergency use authorization of hydroxychloroquine for COVID-19BREAKING: FDA rescinds emergency use authorization for hydroxychloroquine to treat hospitalized COVID-19 patients, saying the drug carries too many risks without any apparent benefit.
Read more »
FDA revokes emergency use of hydroxychloroquineHydroxychloroquine is unlikely 'to be effective in treating COVID-19 for the authorized uses in the EUA,' the FDA says.
Read more »